Dr. Jennifer Foster, MD
Claim this profileBaylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
Expert in Neuroblastoma
Expert in Cancer
34 reported clinical trials
53 drugs studied
Area of expertise
1Neuroblastoma
Global LeaderStage IV
MYC positive
Stage I
2Cancer
Global LeaderStage IV
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Jennifer Foster, MD is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
CBL0137
for Cancer
This trial tests CBL0137, a drug that blocks signals inside cancer cells, in patients whose solid tumors, including CNS tumors or lymphoma, have returned or not responded to treatment. By interfering with the cells' internal communication, the drug aims to stop their growth and cause them to die. CBL0137, also known as Curaxin, has shown antitumor activity in multiple cancers, including glioblastoma, renal cell carcinoma, melanoma, neuroblastoma, and small cell lung cancer.
Recruiting1 award Phase 1 & 213 criteria
More about Jennifer Foster, MD
Clinical Trial Related2 years of experience running clinical trials · Led 34 trials as a Principal Investigator · 15 Active Clinical TrialsTreatments Jennifer Foster, MD has experience with
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
- Larotrectinib
- Palbociclib
- Erdafitinib
- Selpercatinib
Breakdown of trials Jennifer Foster, MD has run
Neuroblastoma
Cancer
Lymphoma
Relapse
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jennifer Foster, MD specialize in?
Jennifer Foster, MD focuses on Neuroblastoma and Cancer. In particular, much of their work with Neuroblastoma has involved Stage IV patients, or patients who are MYC positive.
Is Jennifer Foster, MD currently recruiting for clinical trials?
Yes, Jennifer Foster, MD is currently recruiting for 13 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Jennifer Foster, MD has studied deeply?
Yes, Jennifer Foster, MD has studied treatments such as Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis, Larotrectinib.
What is the best way to schedule an appointment with Jennifer Foster, MD?
Apply for one of the trials that Jennifer Foster, MD is conducting.
What is the office address of Jennifer Foster, MD?
The office of Jennifer Foster, MD is located at: Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.